The study was conducted to provide insight into real-world Bruton tyrosine kinase (BTK) inhibitor treatment patterns in mantle cell lymphoma, as current data are limited. A real-world analysis of ...

CLL cells are highly dependent on external stimuli for survival and proliferation. Despite their malignant nature, CLL cells retain their susceptibility to external signals in lymph nodes (LNs) and ...

David J. Andorsky, MD, board-certified medical oncologist and hematologist at Rocky Mountain Cancer Centers, discussed findings from a study on patterns of Bruton tyrosine kinase (BTK) inhibitor care ...

Lori A. Leslie, MD, an expert on chronic lymphocytic leukemia, provides a comprehensive overview of BTK inhibitors used in the treatment of CLL. Lori A. Leslie, MD: Let’s talk a bit more about Bruton ...

The US Food and Drug Administration has approved an everolimus-eluting bioresorbable scaffold (Esprit BTK) for patients with below-the-knee (BTK) infrapopliteal disease, according to an announcement ...